WHO ICTRP trial
Effect of terlipressin on severe postreperfusion syndrome during deceased donor…
ChiCTR1800019952 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800019952 |
|---|---|
| Public title | Effect of terlipressin on severe postreperfusion syndrome during deceased donor liver transplantation |
| Scientific title | Effect of terlipressin on severe postreperfusion syndrome during deceased donor liver transplantation: a single-center, double-blind, randomized clinical trial |
| Primary sponsor | Beijing Friendship Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Postreperfusion syndrome |
| Interventions | Experimental group:Infusing terlipressin plus open-label vasopressors to maintain the blood pressure;Control group:Infusing normal saline plus open-label vasopressorse to maintain the blood pressure |
| Registration date | Dec 9, 2018 |
| Target size | Experimental group:32;Control group:32 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: